Fny Investment Advisers, LLC Solid Biosciences Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$21.32 - $46.34 $42,640 - $92,680
-2,000 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$36.35 - $51.7 $36,350 - $51,700
1,000 Added 100.0%
2,000 $94,000
Q2 2018

Jul 18, 2018
BUY
$7.33 - $43.15 $7,330 - $43,150
1,000 New
1,000 $35,000

Others Institutions Holding SLDB

# of Institutions
2
Shares Held
97
Call Options Held
0
Put Options Held
0
View Full List

About Solid Biosciences Inc.

SLDB Quotes by TradingView
  • Ticker SLDB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,533,080
  • Market Cap $40.8M
  • Description
  • Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...
More about SLDB
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email